These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 30467370)
1. Neonatal abstinence syndrome. Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370 [TBL] [Abstract][Full Text] [Related]
2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398 [TBL] [Abstract][Full Text] [Related]
3. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Baldo BA Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419 [TBL] [Abstract][Full Text] [Related]
4. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review. Kelty E; Preen DB CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408 [TBL] [Abstract][Full Text] [Related]
5. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes. MacMillan KDL Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310 [TBL] [Abstract][Full Text] [Related]
7. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis. Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609 [TBL] [Abstract][Full Text] [Related]
8. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome. Bhatt-Mehta V; Jing X; Wang X; Zhu HJ Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548 [TBL] [Abstract][Full Text] [Related]
9. A Practical Approach to Neonatal Opiate Withdrawal Syndrome. Devlin LA; Davis JM Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261 [TBL] [Abstract][Full Text] [Related]
10. Neonatal abstinence syndrome: treatment and pediatric outcomes. Logan BA; Brown MS; Hayes MJ Clin Obstet Gynecol; 2013 Mar; 56(1):186-92. PubMed ID: 23314720 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
12. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences. Isaac L; van den Hoogen NJ; Habib S; Trang T J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100 [TBL] [Abstract][Full Text] [Related]
13. Opioid Use in Pregnancy. Tobon AL; Habecker E; Forray A Curr Psychiatry Rep; 2019 Nov; 21(12):118. PubMed ID: 31734808 [TBL] [Abstract][Full Text] [Related]
14. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches. McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics. van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy and the Opioid Epidemic. Haycraft AL J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087 [TBL] [Abstract][Full Text] [Related]
17. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023 [TBL] [Abstract][Full Text] [Related]
18. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]